Michael S. Cuffe - 10 Feb 2026 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: EVP and Chief Clinical Officer
Signature: /s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol: HCA
Transactions as of: 10 Feb 2026
Net transactions value: -$1,757,677
Form type: 4
Filing time: 12 Feb 2026, 18:38:22 UTC
Previous filing: 05 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Cuffe Michael S.	EVP and Chief Clinical Officer	ONE PARK PLAZA, NASHVILLE	/s/ Kevin A. Ball, Attorney-in-Fact	12 Feb 2026	0001632835

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Award	$0	+9,628	+37%	$0.000000	35,581	10 Feb 2026	Direct	F1
transaction	HCA	Common Stock	Tax liability	$1,757,677	-3,501	-9.8%	$502.05	32,080	10 Feb 2026	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 30, 2023, the reporting person was granted 4,814 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Content

On January 30, 2023, the reporting person was granted 4,814 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted.